Hosted on MSN1mon
Regeneron reports positive results for two anti-coagulant drugsafter unilateral total knee arthroplasty. Regeneron (NASDAQ:REGN) said a pooled analysis showed REGN7508 was superior to enoxaparin and non-inferior to apixaban, and REGN9933 was non-inferior to ...
For patients undergoing elective hip- and knee-replacement surgery ... for dabigatran etexilate showed that it was as effective as enoxaparin for the prevention of VTE, with a similar safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback